Home/ Supplements/ Probiotics/ Probiotic S. boulardii

Probiotic S. boulardii

product on market Capsule Vinco Safety: 100/100
100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • Limited research evidence available for ingredients
B Label Compliance Grade
Label

Product Label

Label for Probiotic S. boulardii
Open Full PDF View on NIH DSLD →
Details

Label Data

1 Capsule(s)
Serving Size
30
Servings
Non-Nutrient/Non-Botanical
Product Type
0%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

Saccharomyces boulardii
250 mg

Other Ingredients

Vegetable Capsule Microcrystalline Cellulose Silica Magnesium Stearate
Claims

Label Claims — Verification

Unverified All Other
Unverified Structure/Function
Info

Product Information

Directions for Use

Directions for use: As a dietary supplement for adults and children twelve or more years of age, take one to three capsules per day, on an empty stomach, in-between meals, or as directed by a qualified healthcare professional.

Warnings & Precautions

Keep out of reach of children

Tamper resistant. Do not purchase if seal is broken.

Formulation Notes

Saccharomyces boulardii is a non-colonizing natural yeast probiotic shown to promote gastrointestinal health and help enhance immune function.

5 billion CFU (250 mg) per serving

Gluten free

No wheat, no gluten, no corn, no dairy, no soy

Additional Information

Store in a cool, dry place. Refrigeration of this product will further extend shelf-life, however it is not absolutely crucial to the products effectiveness.

Professional formulation

Metadata

Product Details

UPC / SKU7 39930 27566 9
DSLD Entry Date2022-01-22
Product TypeNon-Nutrient/Non-Botanical
FormCapsule
BrandVinco
DSLD ID258817
Data Updated2026-04-11
Research

Research Evidence

691
Research Sources
52
Avg Quality
255
Clinical Trial
205
Meta Analysis
123
Rct
81
Systematic Review
18
Cochrane Review
2
Guideline
2
Regulatory Source
1
Other
1
Narrative Review
1
Openfda Safety
A Probiotics for preventing acute upper respiratory tract infections
Systematic Review The Cochrane database of systematic reviews 2022 PubMed DOI
A Probiotics for preventing acute upper respiratory tract infections
Meta Analysis The Cochrane database of systematic reviews 2015 PubMed DOI
A Probiotics for maintenance of remission in ulcerative colitis
Meta Analysis The Cochrane database of systematic reviews 2020 PubMed DOI
A Probiotics for induction of remission in ulcerative colitis
Meta Analysis The Cochrane database of systematic reviews 2020 PubMed DOI
A Probiotics for preventing acute upper respiratory tract infections
Meta Analysis The Cochrane database of systematic reviews 2011 PubMed DOI
A Probiotics for treating eczema
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
A Probiotics for treating acute infectious diarrhoea
Meta Analysis The Cochrane database of systematic reviews 2020 PubMed DOI
A The Gut Microbiome in Depression and Potential Benefit of Prebiotics, Probiotics and Synbiotics: A Systematic Review of Clinical Trials and Observational Studies
Systematic Review International journal of molecular sciences 2022 PubMed DOI
A Probiotics for the prevention of Clostridium difficile-associated diarrhea in adults and children
Meta Analysis The Cochrane database of systematic reviews 2017 PubMed DOI
A Probiotics to prevent infantile colic
Meta Analysis The Cochrane database of systematic reviews 2019 PubMed DOI
View all evidence for Probiotics →
Compare

Similar Products

View all Probiotics products →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.